These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13795778)

  • 21. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
    Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
    Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HYPOKALAEMIC ALKALOSIS IN ADRENAL CARCINOMA.
    KNAPTON PJ
    Lancet; 1965 Aug; 2(7407):346. PubMed ID: 14330115
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics of Cushing's syndrome in Taiwanese.
    Su DH; Chang YC; Chang TC; Chang CC; Tsai KS; Huang TS
    J Formos Med Assoc; 2003 May; 102(5):292-8. PubMed ID: 12874666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLASMA RENIN CONCENTRATION IN HUMAN HYPERTENSION. 1. RELATIONSHIP BETWEEN RENIN, SODIUM, AND POTASSIUM.
    BROWN JJ; DAVIES DL; LEVER AF; ROBERTSON JI
    Br Med J; 1965 Jul; 2(5454):144-8. PubMed ID: 14306581
    [No Abstract]   [Full Text] [Related]  

  • 25. A mineralocorticoid excess syndrome presumably due to excessive secretions of corticosterone.
    COST WS
    Lancet; 1963 Feb; 1(7277):362-3. PubMed ID: 14023251
    [No Abstract]   [Full Text] [Related]  

  • 26. Are the hypokalaemia and hypertension in Cushing's disease caused by apparent mineralocorticoid excess?
    Hermus A; Hobma S; Pieters G; van de Calseyde J; Smals A; Kloppenborg P
    Horm Metab Res; 1991 Nov; 23(11):572-3. PubMed ID: 1816069
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma levels of immunoreactive corticotrophin in patients with Cushing's syndrome.
    Besser GM; Landon J
    Br Med J; 1968 Nov; 4(5630):552-4. PubMed ID: 4301887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal medulla secretion in Cushing's syndrome.
    Mannelli M; Lanzillotti R; Pupilli C; Ianni L; Conti A; Serio M
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1331-5. PubMed ID: 8200934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of vascular function in hypertension due to Cushing's syndrome.
    Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R
    Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood plasma content of thyroxine and thyrotropic hormone in Cushing's syndrome and juvenile dyspituitarism syndrome].
    Aleksandrova GF
    Probl Endokrinol (Mosk); 1977; 23(1):39-42. PubMed ID: 846975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The functional condition of blood-brain barrier in Itsenko-Cushing's disease and diencephalic syndrome of Itsenko-Cushing's disease].
    Gincherman EZ; Balakhovskaia MI
    Probl Endokrinol (Mosk); 1968; 14(4):43-8. PubMed ID: 5734178
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma 17-hydroxycorticosteroids in Cushing's syndrome.
    EKMAN H; HAKANSSON B; McARTHY JD; LEHMANN J; SJOGREN B
    J Clin Endocrinol Metab; 1961 Jun; 21():684-94. PubMed ID: 13726263
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin resistance in Cushing's syndrome.
    Karnieli E; Cohen P; Barzilai N; Ish-Shalom Z; Armoni M; Rafaelov R; Barzilai D
    Horm Metab Res; 1985 Oct; 17(10):518-21. PubMed ID: 3905556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid carcinoma and Cushing's syndrome. A report of two cases with a review of the common features of the "non-endocrine" tumours associated with Cushing's syndrome.
    Williams ED; Morales AM; Horn RC
    J Clin Pathol; 1968 Mar; 21(2):129-35. PubMed ID: 4301476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HORMONAL TREATMENT FOR BILATERAL ADRENALECTOMY].
    PAULLADA JJ; MARQUEZ S
    Gac Med Mex; 1964 Feb; 94():159-70. PubMed ID: 14140044
    [No Abstract]   [Full Text] [Related]  

  • 37. [CUSHING'S SYNDROME WITH PREDOMINANCE OF BONE MANIFESTATIONS].
    TAPELLA PA
    Prensa Med Argent; 1963 Jul; 50():2042-50. PubMed ID: 14104581
    [No Abstract]   [Full Text] [Related]  

  • 38. SUCCESSFUL TREATMENT OF CUSHING'S SYNDROME SECONDARY TO AN ARGENTAFFINOMA BY BILATERAL ADRENALECTOMY.
    PRUNTY FT
    Proc R Soc Med; 1965 Aug; 58(8):573-5. PubMed ID: 14341825
    [No Abstract]   [Full Text] [Related]  

  • 39. Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.
    Otsuki M; Kitamura T; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
    Endocr J; 2016 Nov; 63(11):1017-1023. PubMed ID: 27498594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality in Patients with Endogenous Cushing's Syndrome.
    Javanmard P; Duan D; Geer EB
    Endocrinol Metab Clin North Am; 2018 Jun; 47(2):313-333. PubMed ID: 29754634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.